478 results on '"Moul, J W"'
Search Results
2. A phase 2 multimodality trial of docetaxel/prednisone with sunitinib followed by salvage radiation therapy in men with PSA recurrent prostate cancer after radical prostatectomy
3. Preoperative Staging of Prostate Cancer: The Role of Molecular Markers
4. Impact of NADiA ProsVue PSA slope on secondary treatment decisions after radical prostatectomy
5. Phase III, randomized, placebo-controlled study of once-daily oral zibotentan (ZD4054) in patients with non-metastatic castration-resistant prostate cancer
6. Race is associated with discontinuation of active surveillance of low-risk prostate cancer: Results from the Duke Prostate Center
7. African-American men with low-grade prostate cancer have higher tumor burdens: Results from the Duke Prostate Center
8. Does variation in either age at start of therapy or duration of therapy make chemoprevention with finasteride cost-effective?
9. Predictive value of digital rectal examination for prostate cancer detection is modified by obesity
10. Predicting non-organ-confined prostate cancer in men diagnosed after 2000
11. The effect of race on the discriminatory accuracy of models to predict biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases
12. Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database
13. Race and prostate weight as independent predictors for biochemical recurrence after radical prostatectomy
14. Timing and patterns of recurrences and deaths from prostate cancer following adjuvant pelvic radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate
15. Quantitative expression profile of PSGR in prostate cancer
16. Combination hormonal therapy: a reassessment within advanced prostate cancer
17. External beam radiation therapy after radical prostatectomy: efficacy and impact on urinary continence
18. p53 Immunostaining guided laser capture microdissection (p53-LCM) defines the presence of p53 gene mutations in focal regions of primary prostate cancer positive for p53 protein
19. Pentosan polysulfate decreases prostate smooth muscle proliferation and extracellular matrix turnover
20. Sexual bother and function after radical prostatectomy: predictors of sexual bother recovery in men despite persistent post-operative sexual dysfunction
21. Complete embedding and close step-sectioning of radical prostatectomy specimens both increase detection of extra-prostatic extension, and correlate with increased disease-free survival by stage of prostate cancer patients
22. Investigating the distribution of prostate cancer using three-dimensional computer simulation
23. Initiation of salvage therapy for prostate cancer
24. Primary hormonal therapy for prostate cancer: experience with 135 consecutive PSA-ERA patients from a tertiary care military medical center
25. Re: Risk of Death From Prostate Cancer After Radical Prostatectomy or Brachytherapy in Men With Low or Intermediate Risk Disease
26. Histopathological and biological prognostic risk factors in low stage testicular nonseminomatous germ cell tumors: Implikationen für eine risikoadaptierte Therapie
27. Mature, clinical stage I testicular teratoma: retroperitoneal lymphadenetomy or surveillance?
28. Prostatic carcinosarcoma 15 years after combined external beam radiation and brachytherapy for prostatic adenocarcinoma: a case report
29. Report from Durham
30. Report from Durham
31. Report from Durham
32. Report from Durham
33. Is the PSA test useless?
34. Editorial
35. Editorial
36. Editorial
37. Prostate cancer epidemiology, treatment and outcome from the US Department of Defense (DoD) Center for prostate disease research (CPDR) multicenter database with 345 954 records on 15 063 men
38. The CPDR localized prostate cancer multifocal tissue arrayer project: novel experience with characterization of HER-2/neu expression
39. Immunohistochemical expression of monoclonal antibody 43-9F in testicular germ cell tumours*
40. Primary malignant melanoma of the scrotum
41. FSH suppression and tumour control in patients with prostate cancer during androgen deprivation with a GnRH agonist or antagonist
42. Erratum: Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome
43. Siog (international society of geriatric oncology) localised prostate cancer guidelines proposals in senior adult men
44. Use of prostate-specific antigen in black men: age-adjusted reference ranges for maximal cancer detection
45. Best screening tests for prostate cancer
46. Sexual bother and function after radical prostatectomy: predictors of sexual bother recovery in men despite persistent post-operative sexual dysfunction
47. Race is associated with discontinuation of active surveillance of low-risk prostate cancer: Results from the Duke Prostate Center
48. African-American men with low-grade prostate cancer have higher tumor burdens: Results from the Duke Prostate Center
49. Factors Predicting Early and Late Phase Decline of Sexual Health-Related Quality of Life Following Radical Prostatectomy
50. Investigator-initiated pilot study of sunitinib malate in patients with newly diagnosed prostate cancer prior to prostatectomy: A trial of the DoD/PCF Prostate Cancer Clinical Trials Consortium.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.